ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis.
about
Diagnosis and Treatment of Leptomeningeal Metastasis in Non-small Cell Lung CancerClinical data from the real world: efficacy of Crizotinib in Chinese patients with advanced ALK-rearranged non-small cell lung cancer and brain metastasesAlectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib.Alectinib induces a durable (>15 months) complete response in an ALK-positive non-small cell lung cancer patient who progressed on crizotinib with diffuse leptomeningeal carcinomatosis.Non-small cell lung cancer (NSCLC) and central nervous system (CNS) metastases: role of tyrosine kinase inhibitors (TKIs) and evidence in favor or against their use with concurrent cranial radiotherapy.Sustained release of methotrexate through liquid-crystalline folate nanoparticles.
P2860
ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
ALK inhibitor crizotinib combi ...... leptomeningeal carcinomatosis.
@en
ALK inhibitor crizotinib combi ...... leptomeningeal carcinomatosis.
@nl
type
label
ALK inhibitor crizotinib combi ...... leptomeningeal carcinomatosis.
@en
ALK inhibitor crizotinib combi ...... leptomeningeal carcinomatosis.
@nl
prefLabel
ALK inhibitor crizotinib combi ...... leptomeningeal carcinomatosis.
@en
ALK inhibitor crizotinib combi ...... leptomeningeal carcinomatosis.
@nl
P2093
P1433
P1476
ALK inhibitor crizotinib combi ...... leptomeningeal carcinomatosis.
@en
P2093
Hee Kyung Ahn
Jin Seok Ahn
Jong-Mu Sun
Keunchil Park
Myung-Ju Ahn
Su Jin Lee
Taekyu Lim
P304
P356
10.1016/J.LUNGCAN.2012.02.003
P577
2012-03-03T00:00:00Z